![David Kideckel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Kideckel
Director of Finance/CFO at
RAKOVINA THERAPEUTICS INC.
Net worth: 10 080 $ as of 31/07/2026
Profile
David M.
Kideckel is the founder of Kideckel Advisory Group, Inc., founded in 2021, where the title held is President & Chief Executive Officer.
Current jobs include Executive Chairman at Pharmadrug, Inc. starting in 2025; Director at Kane Biotech, Inc. starting in 2025; Chief Financial Officer & Director at Rakovina Therapeutics, Inc. starting in 2025; and EVP, Head-Strategy & Corporate Development at Delta 9 Cannabis, Inc. starting in 2021.
Former jobs include Analyst & Managing Director at ATB Cormark Capital Markets Inc. from 2018 to 2021; Director of Equity Research at Beacon Securities Limited from 2017 to 2018; Principal at Origin Merchant Partners from 2022 to 2023; and Senior VP, Head-Corporate Development & Strategic at IntelGenx Technologies Corp.
Education includes an MBA from Rotman School of Management and a doctorate from the University of Toronto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARMADRUG, INC. 1.03% | 09/10/2025 | 1,380,000 ( 1.03% ) | 8 280 $ | 31/07/2026 |
| 29/07/2025 | 20,000 ( 0.09% ) | 1 800 $ | 31/07/2026 | |
KANE BIOTECH INC. -.--% | 28/05/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
David Kideckel active positions
| Companies | Position | Start |
|---|---|---|
| HUMBLE GROW CO. | Corporate Officer/Principal | 16/08/2021 |
| PHARMADRUG INC. | Chairman | 27/02/2024 |
| RAKOVINA THERAPEUTICS INC. | Director of Finance/CFO | 01/05/2025 |
| KANE BIOTECH INC. | Director/Board Member | 25/06/2025 |
Former positions of David Kideckel
| Companies | Position | End |
|---|---|---|
Origin Merchant Partners
 Origin Merchant Partners Investment Banks/BrokersFinance Provides investment banking services | Corporate Officer/Principal | 01/01/2023 |
ATB Cormark Capital Markets Inc.
 ATB Cormark Capital Markets Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/08/2021 |
Beacon Securities Ltd.
 Beacon Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Director of Research - Equity | 01/10/2018 |
| INTELGENX TECHNOLOGIES CORP. | Corporate Officer/Principal | - |
Training of David Kideckel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Kane Biotech, Inc.
 Kane Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that manufactures animal health oral care products | Commercial Services |
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ATB Cormark Capital Markets Inc.
ATB Cormark Capital Markets Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Securities Ltd.
Beacon Securities Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
IntelGenx Technologies Corp.
 IntelGenx Technologies Corp. Pharmaceuticals: MajorHealth Technology Operates as a drug delivery company that develops and manufactures oral film therapeutics | Health Technology |
Origin Merchant Partners
Origin Merchant Partners Investment Banks/BrokersFinance Provides investment banking services | Finance |
Delta 9 Cannabis, Inc.
 Delta 9 Cannabis, Inc. Wholesale DistributorsDistribution Services Wholesales and retails cannabis products | Distribution Services |
Pharmadrug, Inc.
 Pharmadrug, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development of cannabis-infused edible products and oil extracts | Health Technology |
Rakovina Therapeutics, Inc.
 Rakovina Therapeutics, Inc. Financial ConglomeratesFinance Develops oncology therapeutics | Finance |
- Stock Market
- Insiders
- David Kideckel
